Key facts
- It has raised $13.8M; the latest was Accelerator/Incubator in Dec 2024.
- Notable investors include European Union, Innovation Authority, A-Labs, Business in Space Growth Network, European Innovation Council (Belgium) — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for SpacePharma
- ·The full record, as it builds
Funding rounds
No funding rounds for SpacePharma are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About SpacePharma
Provider of micro-gravity research services designed to promote the discovery of new factors involved in the pathogenicity of bacteria. The company develops end-to-end miniaturized lab systems provided with sensors and readers, capable of working on different microgravity platforms, assists its customers in all phases of performing experiments in microgravity, enabling researchers to perform selected top-notch microgravity assays and provides novel data, and accelerates research and development pipelines remotely.
- Sector
- Healthcare
- HQ
- Herzliya, Israel
- Founded
- 2012
- Employees
- 24
- Website
- spacepharma.health/
- Ownership
- Privately Held (backing)
SpacePharma doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in SpacePharma shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on SpacePharma in its N-PORT filings yet. We sweep new filings monthly.